2014 - 07 - 23
Marylène D'Incau, research Nurse at the Centre For Health Studies.
“Population health will always be a major issue and we are all concerned. That is why we are numerous of different actors working together for one single goal: improving public health. As a nurse, my mission is the assessment of healthy as well as of ill civilians taking part in our studies as well as to help them managing healthy behavior. CRP-Santé needs participants helping research go further in promoting health and preventing diseases like diabetes, high blood pressure, cardiovascular issues and many more”.
Dr. Manon Gantenbein, Associate Head of Unit at the Clinical and Epidemiological Investigation Center.
“Clinical research and medicines development have fascinated me all along since I am a teenager: I was determined to learn more about it. Today, clinical research is essential as we owe today’s innovative medicines to clinical research and further, tomorrow's medicines cannot be developed without. The inception of the Clinical and Epidemiological Investigation Center (CIEC) has enabled me to develop further my knowledge acquired abroad, including work experiences in France and Germany in hospital clinical research unit, CRO and pharmaceutical industry. I apply it here for the benefit of patients in Luxembourg”.
Arnaud Muller, Bioinformatician at the Genomics Research unit.
“My first step as an engineer consisted in the implementation of a technical bioinformatics platform followed by data analysis of microarrays: this was the beginning of high throughput biology at CRP-Santé". We are now facing another technology transition with second generation sequencing. This transforms today’s genomics into unprecedented scales, either in terms of size and accuracy. My job is to take up these new challenges in a tailor-made fashion and to deliver results ready for interpretation. This is my contribution to extend throughput biology into integrative biology”.
Dr. Andy Chevigné, Researcher at the Laboratory of Retrovirology.
“Chemokine receptors are key players of cell communication and an entry door for HIV-1. At the Laboratory of Retrovirology, we investigate the structural and functional determinants of these receptors to decipher the mechanisms by which they recognise their ligands and to develop novel therapeutics to shut the door on HIV-1”.
Dr. Yeoun Jin Kim, Associate Head of the Luxembourg Clinical Proteomic Center (LCP)
“I have been working in pharmaceutical companies where I was confronted with challenges in developing cancer drugs. At the Luxembourg Clinical Proteomics Center, my journey to find biomarkers for personalized medicine, especially for lung cancer, has begun. Biomarkers we are searching for should be able to warn patients about the presence of cancer early enough to be promptly treated and to help clinicians to choose the right drugs for patients. I am devoted every day: I know we can change the life of patients”.